BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 543907)

  • 1. Local tolerance of i.m. mezlocillin injection.
    Belli L; Gandolfo S; Varela M; Gennaro EA
    Arzneimittelforschung; 1979; 29(12a):1985-7. PubMed ID: 543907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed combination mezlocillin/oxacillin injected intramuscularly. Comparative study of local tolerability compared with ampicillin and determination of effectiveness and tolerability in the treatment of surgical and urinary tract infections.
    Belli L; Freylejer A; Ginesín LM; Ríos JF; Gandolfo S
    Arzneimittelforschung; 1980; 30(10):1804-7. PubMed ID: 6449205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid penetration of mezlocillin.
    Modai J; Pierre J; Bergogne-Berezin E; Avril MF
    Arzneimittelforschung; 1979; 29(12a):1967-9. PubMed ID: 543903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
    Knothe H
    Arzneimittelforschung; 1979; 29(12a):1916-20. PubMed ID: 120745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with mezlocillin in infections of mouth and jaw (author's transl)].
    Shimizu M; Amagasa M; Ohnishi M; Yuki K; Sato T; Yoshida H; Do K; Ueno M
    Arzneimittelforschung; 1979; 29(12a):1987-9. PubMed ID: 543908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies with a mezlocillin-oxacillin combination in a children's intensive care ward].
    Schöch G
    Arzneimittelforschung; 1979; 29(12a):2017-20. PubMed ID: 543916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with the combination mezlocillin/oxacillin in severe bacterial infections in a children's surgical ward (author's transl)].
    Kurz R
    Arzneimittelforschung; 1979; 29(12a):2014-7. PubMed ID: 543915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a multicentric clinical study of mezlocillin in Japan (author's transl)].
    Fujii R
    Arzneimittelforschung; 1979; 29(12a):2005-8. PubMed ID: 396930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood meningitis with mezlocillin.
    Llorens-Terol J; Lobato A; Adam D
    Arzneimittelforschung; 1979; 29(12a):2001-2. PubMed ID: 543912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mezlocillin concentrations in human bone tissue].
    Vent J
    Arzneimittelforschung; 1979; 29(12a):1969-71. PubMed ID: 543904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy with an antibiotic combination mezlocillin/oxacillin and clinical experience/Second communication: Children (author's transl)].
    Chyský V; Hullmann R
    Arzneimittelforschung; 1979; 29(12a):2028-31. PubMed ID: 543917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin.
    Soares LA; Trabulsi LR
    Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic therapy of infections in patients under surgical intensive care, in particular with mezlocillin (author's transl)].
    Haldemann G; Haldemann M; Rieschel H; Weuta H
    Arzneimittelforschung; 1979; 29(12a):1995-9. PubMed ID: 261572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electron microscopic and microbiological studies on the activity of mezlocillin against Escherichia coli (author's transl)].
    Voigt WH; Metzger KG
    Arzneimittelforschung; 1979; 29(12a):1939-41. PubMed ID: 396928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecid.
    Verbist L; Tjandramaga TB; Verbesselt R; De Schepper PJ
    Arzneimittelforschung; 1979; 29(12a):1962-6. PubMed ID: 543902
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.